Protein Kinase Inhibitors
7 clinical trials · Condition
◉ Watch Protein Kinase Inhibitors
| Record | Firm | Date |
|---|---|---|
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC (NCT04518852) | Sichuan Cancer Hospital and Research Institute | 2020-09-14 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
Track Protein Kinase Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.